Who owns OLEMA PHARMACEUTICALS INC?
- Ticker: OLMA
- CUSIP Number: 68062p106
Tip: Access positions for across all investors
Analyze quarterly positions in Olema Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Olema Pharmaceuticals stock
Who bought or sold OLEMA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
|---|---|---|---|---|---|---|
| Henderson Group | 3.6M | $114M | -2% | Mar 2021 | ||
| Wellington Management Company | 2.0M | $66M | -3% | Mar 2021 | ||
| VR Adviser | 1.5M | $51M | 0% | Mar 2021 | ||
| BlackRock | 1.5M | $48M | 112% | Mar 2021 | ||
| Citadel Advisors | 1.4M | $48M | 0% | Mar 2021 | ||
| Vanguard Group | 926k | $31M | 15% | Mar 2021 | ||
| venBio Select Advisor | 877k | $25M | 0% | Mar 2021 | ||
| FMR | 653k | $22M | 0% | Mar 2021 | ||
| Ameriprise Financial | 465k | $15M | 27% | Mar 2021 | ||
| Foresite Capital Management IV | 393k | $13M | -52% | Mar 2021 | ||
| Franklin Resources | 370k | $12M | 0% | Mar 2021 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Olema Pharmaceuticals? |
||||||
| Artal Group | 261k | $8.6M | 0% | Mar 2021 | ||
| Federated Investors | 260k | $8.6M | 0% | Mar 2021 | ||
| Tybourne Capital Management | 260k | $8.6M | 0% | Mar 2021 | ||
| Invesco | 246k | $8.2M | -54% | Mar 2021 | ||
| Geode Capital Management | 214k | $7.1M | 708% | Mar 2021 | ||
| State Street Corporation | 174k | $5.8M | 100% | Mar 2021 | ||
| Driehaus Capital Management | 172k | $5.7M | -37% | Mar 2021 | ||
| Pictet Asset Management | 170k | $5.6M | 6% | Mar 2021 | ||
| Northern Trust | 130k | $4.3M | 836% | Mar 2021 | ||
| Jpmorgan Chase & Co | 100k | $3.4M | 36% | Mar 2021 | ||
| Point72 Asset Management | 94k | $3.1M | 100% | Mar 2021 | ||
| Charles Schwab Investment Management | 79k | $2.6M | 100% | Mar 2021 | ||
| Nuveen Asset Management | 44k | $1.5M | 100% | Mar 2021 | ||
| Susquehanna International | 43k | $1.4M | 0% | Mar 2021 | ||
| Bank of New York Mellon | 32k | $1.1M | 100% | Mar 2021 | ||
| Parametric Portfolio Associates | 30k | $1.0M | 22% | Mar 2021 | ||
| Bank of America Corporation | 27k | $910k | 28759% | Mar 2021 | ||
| CalPERS | 22k | $737k | -9% | Mar 2021 | ||
| Goldman Sachs Group | 21k | $700k | -62% | Mar 2021 | ||
| California State Teachers Retirement System | 18k | $607k | 100% | Mar 2021 | ||
| Athanor Capital | 16k | $533k | 208% | Mar 2021 | ||
| HighVista Strategies | 15k | $480k | 100% | Mar 2021 | ||
| Jasper Ridge Partners | 14k | $475k | 100% | Mar 2021 | ||
| Deutsche Bank Aktiengesellschaft | 14k | $454k | 100% | Mar 2021 | ||
| Sectoral Asset Management | 13k | $428k | 100% | Mar 2021 | ||
| Hamilton Lane Advisors | 12k | $402k | 100% | Mar 2021 | ||
| Rhumbline Advisers | 11k | $364k | 100% | Mar 2021 | ||
| T. Rowe Price Associates | 8.5k | $280k | 100% | Mar 2021 | ||
| American International | 7.1k | $235k | 100% | Mar 2021 | ||
| Capstone Investment Advisors | 6.9k | $230k | 100% | Mar 2021 | ||
| Manufacturers Life Insurance Company | 6.8k | $227k | 100% | Mar 2021 | ||
| Ensign Peak Advisors | 6.6k | $219k | 100% | Mar 2021 | ||
| American Financial Group | 6.4k | $212k | 100% | Mar 2021 | ||
| New York State Common Retirement Fund | 6.0k | $199k | 100% | Mar 2021 | ||
| MetLife Investment Advisors | 5.6k | $186k | 100% | Mar 2021 | ||
| Wells Fargo & Company | 3.8k | $128k | 12697% | Mar 2021 | ||
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.9k | $96k | 100% | Mar 2021 | ||
| Maven Securities | 2.3k | $78k | -58% | Mar 2021 | ||
| Legal & General Group | 1.2k | $41k | 100% | Mar 2021 | ||
| Citigroup | 1.2k | $39k | -83% | Mar 2021 | ||
| Tower Research Capital | 1.2k | $39k | 105% | Mar 2021 | ||
| Royal Bank of Canada | 1.1k | $37k | 100% | Mar 2021 | ||
| Summit Investment Advisors | 987.00 | $33k | 100% | Mar 2021 | ||
| UBS Group | 636.00 | $21k | -99% | Mar 2021 | ||
| Bank Of Montreal | 378.00 | $12k | 100% | Mar 2021 | ||
| Bessemer | 64.00 | $2.0k | 100% | Mar 2021 | ||
| Private Capital Group | 31.00 | $1.0k | 100% | Mar 2021 | ||
| Us Bancorp | 18.00 | $1.0k | 100% | Mar 2021 | ||
| Candriam Luxembourg S.C.A. | 13.00 | $0 | 100% | Mar 2021 | ||
| Metropolitan Life Insurance Company | 4.00 | $136.000000 | 100% | Mar 2021 | ||
Who sold out of Olema Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Avidity Partners Management | Dec 2020 | 270k | $13M |
| Morgan Stanley | Dec 2020 | 46k | $2.2M |
| Atom Investors | Dec 2020 | 25k | $1.2M |
| Hrt Financial | Dec 2020 | 23k | $1.1M |
| ExodusPoint Capital Management | Dec 2020 | 22k | $1.0M |
| Pinz Capital Management | Dec 2020 | 18k | $856k |
| Sphera Funds Management | Dec 2020 | 15k | $731k |
| Jefferies Group | Dec 2020 | 15k | $726k |
| SG Americas Securities | Dec 2020 | 12k | $591k |
| Tibra Equities Europe | Dec 2020 | 12k | $591k |
| Mirabella Financial Services | Dec 2020 | 11k | $505k |
| Qube Research & Technologies | Dec 2020 | 8.9k | $427k |
| Windsor Creek Advisors | Dec 2020 | 6.0k | $288k |
| M^T Bank Corporation | Dec 2020 | 5.3k | $254k |
| Kinloch Capital | Dec 2020 | 500.00 | $24k |